Price controls seen as key to Europe's drug innovation lag

被引:4
|
作者
Mitchell, Peter
机构
关键词
D O I
10.1038/nrd2293
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Pharmaceutical innovation is not only occurring faster in the United States than in Europe, but the gap is getting wider.
引用
收藏
页码:257 / 258
页数:2
相关论文
共 50 条
  • [1] Price controls seen as key to Europe's drug innovation lag
    Peter Mitchell
    Nature Reviews Drug Discovery, 2007, 6 : 257 - 258
  • [2] Drug innovation, price controls, and parallel trade
    Matteucci, Giorgio
    Reverberi, Pierfrancesco
    INTERNATIONAL JOURNAL OF HEALTH ECONOMICS AND MANAGEMENT, 2017, 17 (02) : 159 - 179
  • [3] Drug innovation, price controls, and parallel trade
    Giorgio Matteucci
    Pierfrancesco Reverberi
    International Journal of Health Economics and Management, 2017, 17 : 159 - 179
  • [4] WAGE AND PRICE CONTROLS AS SEEN BY A CONTROLLER
    DUNLOP, JT
    LABOR LAW JOURNAL, 1975, 26 (08) : 457 - 463
  • [5] Parallel imports, price controls, and innovation
    Reisinger, Markus
    Sauri, Lluis
    Zenger, Hans
    JOURNAL OF HEALTH ECONOMICS, 2019, 66 : 163 - 179
  • [6] A study on drug innovation lag in Taiwan
    Chung, CJ
    Huang, WF
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2006, 14 (01) : 1 - 6
  • [7] DRUG LAG - DOES IT EXIST IN EUROPE
    HAEN, PD
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1975, 9 (03): : 144 - 150
  • [8] FDA chief attacks Canada's drug price controls
    Webster, P
    LANCET, 2003, 362 (9398): : 1816 - 1816
  • [9] THE EFFECT OF INNOVATION LAG ON DRUG ACCESS IN TAIWAN
    Hsieh, C.
    Tasi, Y.
    Chiang, Y.
    Huang, W.
    VALUE IN HEALTH, 2015, 18 (03) : A88 - A89
  • [10] Price movements in Europe hold the key
    Anon
    Paper Market Digest, 2000, 18 (04):